Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 201–250 of 254 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05371132	Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)	recruiting	Phase 1	10	City of Hope Medical CenterOTHER	1	Jan 28, 2026	clinicaltrials
NCT07371663	An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors	recruiting	Phase 1 / Phase 2	266	Beijing Tide Pharmaceutical Co., LtdINDUSTRY	1	Jan 28, 2026	clinicaltrials